T cell survival and function requires the c-Abl tyrosine kinase

Cell Cycle

Volumn 7, Issue 24, 2008, Pages 3847-3857

  Silberman, Isabelle ^a   Sionov, Ronit Vogt ^a   Zuckerman, Valentina ^a   Haupt, Sue ^c   Goldberg, Zehavit ^a   Strasser, Andreas ^b   Ben Sasson, Zami S ^a   Baniyash, Michal ^a   Koleske, Anthony J ^d   Haupt, Ygal ^a,c  

^a HEBREW UNIVERSITY   (Israel)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; c Abl; Mitogenic activation; T cell; Tumor rejection

Indexed keywords

ABELSON KINASE; ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; T LYMPHOCYTE; THYMUS ATROPHY; TUMOR REJECTION;

MUS;

EID: 58049221051     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.24.7267     Document Type: Article

References (37)

1. Pendergast AM. The Abl family kinases: mechanisms of regulation and signaling. Adv Cancer Res 2002; 85:51-100.
2. Zhu J, Wang JY. Death by Abl: a matter of location. Curr Top Dev Biol 2004; 59:165-92.
3. Hernandez SE, Krishnaswami M, Miller AL, Koleske AJ. How do Abl family kinases regulate cell shape and movement? Trends Cell Biol 2004; 14:36-44.
4. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991; 65:1153-63.
5. Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, et al. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 1991; 65:1165-75.
6. Mattiuzzi GN, Cortes JE, Talpaz M, Reuben J, Rios MB, Shan J, et al. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res 2003; 9:976-80.
7. Li B, Boast S, de los Santos K, Schieren I, Quiroz M, Teitelbaum SL, et al. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 2000; 24:304-8.
8. Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, Miczek KA, Baltimore D. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 1998; 21:1259-72.
9. Moresco EM, Donaldson S, Williamson A, Koleske AJ. Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. J Neurosci 2005; 25:6105-18.
10. Hardin JD, Boast S, Schwartzberg PL, Lee G, Alt FW, Stall AM, Goff SP. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell Immunol 1995; 165:44-54.
11. Shimizu C, Kawamoto H, Yamashita M, Kimura M, Kondou E, Kaneko Y, et al. Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Int Immunol 2001; 13:105-17.
12. +) thymocytes in normal and genetically modified mice. J Immunol 1995; 154:5103-13.
13. - murine thymocytes: differences in proliferation rate in vivo and proliferative responses in vitro. Eur J Immunol 1988; 18:261-8.
14. Reddy M, Eirikis E, Davis C, Davis HM, Prabhakar U. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J Immunol Methods 2004; 293:127-42.
15. Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Semin Immunopathol 2005; 27:37-48.
16. Ben-David Y, Yefenof E, Kotler M. Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells. Cancer Res 1987; 47:6590-4.
17. Ciofani M, Zuniga-Pflucker JC. The Thymus as an Inductive Site for T Lymphopoiesis. Annu Rev Cell Dev Biol 2006.
18. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006; 6:127-35.
19. Shaul Y, Ben-Yehoyada M. Role of c-Abl in the DNA damage stress response. Cell Res 2005; 15:33-5.
20. Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y. C-Abl as a modulator of p53. Biochem Biophys Res Commun 2005; 331:737-49.
21. Dorsch M, Goff SP. Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. Proc Natl Acad Sci USA 1996; 93:13131-6.
22. Lam QL, Lo CK, Zheng BJ, Ko KH, Osmond DG, Wu GE, Rottapel R, Lu L. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice. Int Immunol 2007; 19:267-76.
23. Suzuki J, Shishido T. Regulation of cellular transformation by oncogenic and normal Abl kinases. J Biochem (Tokyo) 2007; 141:453-8.
24. Chopra R, Pu QQ, Elefanty AG. Biology of BCR-ABL. Blood Rev 1999; 13:211-29.
25. Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R. Subcellular localization of Bcr, Abl and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 1993; 92:1925-39.
26. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286:1735-8.
27. Sohn SJ, Thompson J, Winoto A. Apoptosis during negative selection of autoreactive thymocytes. Curr Opin Immunol 2007; 19:510-5.
28. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994; 12:456-65.
29. Bhandoola A, Sambandam A. From stem cell to T cell: one route or many? Nat Rev Immunol 2006; 6:117-26.
30. Salmon M, Bacon PA, Symmons DP, Walton KW. Transferrin receptor expression by stimulated cells in mixed lymphocyte culture. Immunology 1985; 54:559-64.
31. Hardin JD, Boast S, Schwartzberg PL, Lee G, Alt FW, Stall AM, Goff SP. Abnormal peripheral lymphocyte function in c-abl mutant mice. Cell Immunol 1996; 172:100-7.
32. Zipfel PA, Zhang W, Quiroz M, Pendergast AM. Requirement for Abl kinases in T cell receptor signaling. Curr Biol 2004; 14:1222-31.
33. Gao B, Lee SM, Fang D. The tyrosine kinase c-Abl protects c-Jun from ubiquitination-mediated degradation in T cells. J Biol Chem 2006; 281:29711-8.
34. Huang Y, Comiskey EO, S. DR, Li S, Koleske AJ, Burkhardt JK. The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse. Blood 2008; 112:111-9.
35. Gu JJ, Zhang N, He YW, Koleske AJ, Pendergast AM. Defective T cell development and function in the absence of Abelson kinases. J Immunol 2007; 179:7334-43.
36. + T cell help in cancer immunity and the formulation of novel cancer vaccines. Cancer Immunol Immunother 2007; 56:70-80.
37. Honigman A, Zeira E, Ohana P, Abramovitz R, Tavor E, Bar I, Zilberman Y, et al. Imaging transgene expression in live animals. Mol Ther 2001; 4:239-49.